Camp4 Therapeutics (CAMP) Free Cash Flow (2023 - 2026)
Camp4 Therapeutics (CAMP) reported Free Cash Flow of -$11.0 million for Q1 2026, up 23.13% on a YoY basis from -$8.9 million in Q1 2025, and down 275.78% sequentially from $6.2 million in Q4 2025.
Camp4 Therapeutics (CAMP) Free Cash Flow (2023 - 2026) Analysis & Trends
Camp4 Therapeutics (CAMP) has 4 years of Free Cash Flow data on file, last reported at -$11.0 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 23.13% year-over-year to -$11.0 million; the trailing twelve-month figure through Mar 2026 stood at -$26.5 million (up 45.86% YoY), and the FY2025 full-year result was -$29.8 million, up 35.15% from the prior year.
- Free Cash Flow fell to -$11.0 million in Q1 2026, from $6.2 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $6.2 million in Q4 2025 to a low of -$14.3 million in Q1 2025.
- A 4-year average of -$9.9 million and a median of -$11.2 million in 2024 frame the typical range for Free Cash Flow.
- Peak annual rise in Free Cash Flow reached 154.08% in 2025, while the deepest fall reached 26.49% in 2025.
- Tracing CAMP's Free Cash Flow over 4 years: stood at -$12.4 million in 2023, then increased by 6.88% to -$11.6 million in 2024, then soared by 154.08% to $6.2 million in 2025, then plunged by 275.78% to -$11.0 million in 2026.
- Business Quant data shows CAMP's Free Cash Flow at -$11.0 million in Q1 2026, $6.2 million in Q4 2025, and -$11.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Camp4 Therapeutics | 174.35 Mn | 174.35 Mn | - | -10.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.98 Mn |
| Mar 31, 2026 | -10.98 Mn |
| Dec 31, 2025 | 6.25 Mn |
| Dec 31, 2025 | 6.25 Mn |
| Sep 30, 2025 | -11.17 Mn |
| Sep 30, 2025 | -11.17 Mn |
| Jun 30, 2025 | -10.62 Mn |
| Jun 30, 2025 | -10.62 Mn |
| Mar 31, 2025 | -14.29 Mn |
| Mar 31, 2025 | -14.29 Mn |
| Dec 31, 2024 | -11.55 Mn |
| Dec 31, 2024 | -11.55 Mn |
| Sep 30, 2024 | -9.69 Mn |
| Sep 30, 2024 | -9.69 Mn |
| Jun 30, 2024 | -13.47 Mn |
| Jun 30, 2024 | -13.47 Mn |
| Mar 31, 2024 | -11.29 Mn |
| Mar 31, 2024 | -11.29 Mn |
| Dec 31, 2023 | -12.41 Mn |
| Dec 31, 2023 | -12.41 Mn |